Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. IMCR
IMCR logo

IMCR

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IMCR News

Black Diamond Therapeutics Shares Plunge 35.8% Amid Mixed Phase II Results

6d agoNASDAQ.COM

Immunocore Q1 Earnings Beat Expectations

May 07 2026seekingalpha

Immunocore Holdings Shares Show Oversold Signal

Apr 27 2026NASDAQ.COM

KIMMTRAK Doubles Five-Year Survival Rate for Metastatic Uveal Melanoma Patients

Apr 19 2026Newsfilter

KIMMTRAK Doubles Five-Year Survival Rate for Metastatic Uveal Melanoma Patients

Apr 19 2026Yahoo Finance

Immunocore (IMCR) Q4 2025 Earnings Call Transcript

Feb 25 2026NASDAQ.COM

Immunocore Q4 Earnings Report Analysis

Feb 25 2026seekingalpha

Immunocore Set to Announce Q4 Earnings on February 25

Feb 24 2026seekingalpha

Immunocore Announces R&D Leadership Changes

Jan 30 2026Newsfilter

Immunocore to Showcase at Upcoming Investor Events

Nov 10 2025Newsfilter

HC Wainwright & Co. Affirms Buy Rating for Immunocore Holdings, Keeps $100 Price Target Intact

Oct 22 2025Benzinga

H.C. Wainwright Maintains Positive Outlook on Immunocore Holdings plc (IMCR)

Oct 21 2025Yahoo Finance

Resolution Therapeutics names Lucy Singah as CFO and Daniel Kennedy as CBO

Sep 10 2025Newsfilter

Immunocore Holdings plc (IMCR) Q2 2025 Earnings Call Transcript

Aug 09 2025Newsfilter

IOVA Q2 Earnings Miss, Stock Down on EMA Filing Withdrawal for Amtagvi

Aug 08 2025NASDAQ.COM

RXRX Q2 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down

Aug 06 2025NASDAQ.COM